YZY BIO

yzy-bio-logo

YZY Bio is a biotechnology company that develops anti-tumor bispecific antibodies based on breakthrough discoveries in molecular biology, enabling patients with major diseases to obtain more efficient treatment solutions.

#SimilarOrganizations #People #Financial #Website #More

YZY BIO

Social Links:

Industry:
Biotechnology Health Care Pharmaceutical Product Research

Founded:
2010-07-01

Address:
Wuhan, Hubei, China

Country:
China

Website Url:
http://www.yzybio.com

Total Employee:
51+

Status:
Active

Contact:
86 27 82668988

Email Addresses:
[email protected]

Total Funding:
450 M CNY


Similar Organizations

astrogen-logo

Astrogen

Astrogen is a biotech company developing new drugs.

autotelic-bio-logo

Autotelic Bio

Autotelic Bio is a bio technology company that researches and develops anti-cancer drugs.

imvax-logo

Imvax

Imvax is a biotechnology company focused on the development of novel patient-specific vaccines and immunotherapy strategies.

innovent-biologics-logo

Innovent Biologics

Innovent Biologics is a biopharmaceutical company that develops and manufactures monoclonal antibodies.

nutcracker-therapeutics-logo

Nutcracker Therapeutics

Nutcracker Therapeutics is a biotech company that develops mRNA therapeutics.

tcr2-logo

TCR2

TCR2 is a discovery stage pharmaceutical company that developed a unique proprietary TRuC™ platform.

Current Employees Featured

pengfei-zhou_image

Pengfei Zhou
Pengfei Zhou Founder and CEO @ YZY Bio
Founder and CEO

Founder


pengfei-zhou_image

Pengfei Zhou

Investors List

wuhan-institute-of-biotechnology_image

Wuhan Institute of Biotechnology

Wuhan Institute of Biotechnology investment in Series B - YZY Bio

bgi-co-win_image

BGI Co-Win

BGI Co-Win investment in Series B - YZY Bio

sanhua-hongdao-investment_image

Sanhua Hongdao Investment

Sanhua Hongdao Investment investment in Series B - YZY Bio

td-capital-88bb_image

TD Capital

TD Capital investment in Series B - YZY Bio

Official Site Inspections

http://www.yzybio.com

  • Host name: 121.199.6.220
  • IP address: 121.199.6.220
  • Location: Hangzhou China
  • Latitude: 30.294
  • Longitude: 120.1619
  • Timezone: Asia/Shanghai

Loading ...

More informations about "YZY Bio"

Company Overview - About YZYBIO - Wuhan YZY Biopharma Co., …

Dr. Yang Bin currently serves as the vice president of the manufacturing center of the Company, who is responsible for implementing the Group’s strategies and goals for technology …See details»

公司介绍 - 关于我们 - 武汉友芝友生物制药 - YZY Bio

武汉友芝友生物制药股份有限公司成立于2010年,是一家致力于开发双特异性抗体 (BsAb)疗法的生物技术公司。公司已前瞻性布局包括但不限于肿瘤并发症、肿瘤、眼科、自身免疫疾病等在 …See details»

Wuhan YZY Biopharma Co., Ltd.-友芝友生物制药

Wuhan YZY Biopharma Co., Ltd. is a biotechnology company dedicated to developing bispecific antibody (BsAb)-based therapies to treat cancer-associated complications, cancer and age …See details»

Board of Directors - Corporate Governance - Investor Relations

TERMS OF REFERENCE OF THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS <1 2 3 4> Phone: 027-82668988 E-Mail:[email protected] Address:Biolake, C2-1, No. 666 High ...See details»

Wuhan YZY Biopharma Co., Ltd. - Patsnap

Explore Wuhan YZY Biopharma Co., Ltd. with its drug pipeline, therapeutic area, technology platform, 18 clinical trials, 1 news, and 21 literature, Disease Domain:Neoplasms, …See details»

YZY Bio - Crunchbase Company Profile & Funding

YZY Bio is a biotechnology company that develops anti-tumor bispecific antibodies.See details»

Wuhan YZY Biopharma - ZoomInfo

View Wuhan YZY Biopharma (www.yzybio.com) location in Hubei, China , revenue, industry and description. Find related and similar companies as well as employees by title and much more.See details»

Organization: Wuhan YZY Biopharma - Cbonds.com

Wuhan YZY Biopharma. Information about the issuer. News and credit ratings. . Tables with accounting and financial reporting.See details»

Wuhan YZY Biopharma - Company Profile - Tracxn

Nov 13, 2024 Wuhan YZY Biopharma - Developer of bi-specific antibodies for cancer treatment. Public Company. Raised a total funding of $29.8M over 4 rounds from 6 investors.See details»

公告与通函 - 信息披露 - 投资者关系 - 武汉友芝友生物制药

公司治理信息披露投资者关系日历网络直播与演示文稿新闻发布无纸化公司通讯See details»

YZY Bio Company Profile 2024: Stock Performance & Earnings

Information on stock, financials, earnings, subsidiaries, investors, and executives for YZY Bio. Use the PitchBook Platform to explore the full profile.See details»

Wuhan YZY Biopharma Co., Ltd. - synapse.zhihuiya.com

了解Wuhan YZY Biopharma Co., Ltd. (武汉友芝友生物制药股份有限公司)公司的药物管线,治疗领域,技术平台,以及它的18项临床试验, 139篇新闻和21篇文献,疾病领域:肿瘤,内分泌与 …See details»

Wuhan YZY Biopharma Co. Ltd. - ContactOut

Wuhan YZY Biopharma Co. Ltd. YZY Biopharma is a biotech company whose vision is to develop new class of innovative medicines based on breakthrough discovery in molecular biology. The …See details»

Financial Reports - Information Disclosure - Investor Relations

Home About YZYBIO Company OverviewLeadership TeamMilestonesContact Us Science and Technology Research AreaTechnology PlatformsProduct PipelineProduction …See details»

Congratulations to Wuhan YZY Biopharma Co Ltd (2496.HK) on its ...

Sep 25, 2023 Founded in 2010, Wuhan YZY Biopharma Co., Ltd. is a biotechnology company dedicated to developing BsAb-based therapies to treat cancer-associated complications, …See details»

RD Center - Products and Research - Wuhan YZY Biopharma Co., Ltd.

With the mission of "Develop innovative drugs to safeguard human health", YZYBIO has established a visionary and seasoned R&D team and an integrated research and development …See details»

Wuhan YZY Biopharma Co. Ltd. Email Format | yzybio.com Emails

5 free lookups per month. No credit card required. The most common Wuhan YZY Biopharma Co. Ltd. email format is [first]. [last] (ex. [email protected]), which is being used by 50.0% of …See details»

Research Area - Science and Technology - Wuhan YZY Biopharma …

YZYBIO’s QMS covers all aspects of operations, including process development, procurement, product manufacturing, product storage, and transportation. YZYBIO has established …See details»

Products - RD Center - Products and Research - Wuhan YZY …

On July 26, 2022, YZYBIO entered into an asset transfer agreement with Shenzhen Kangzhe Vision Pharmaceutical Development Co.,Ltd. (深圳市康哲维盛医药发展有限责任公司)(“CMS …See details»

linkstock.net © 2022. All rights reserved